Akebia Therapeutics (AKBA) Q2 2023 Earnings

25AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.28
-0.19
-0.11
-0.02

Details

Expected EPS
-0.02
Actual EPS
-0.06
Surprise EPS
-0.04
Surprise Percent
+200%

Description

Akebia Therapeutics (AKBA) has reported earnings of -0.06 per share for Q2 2023.

0 Comments

Share your thoughts